+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Endothelin receptor antagonist Bosentan attenuates leukocyte-endothelial adhesion and inflammation in a rat model of IBD



Endothelin receptor antagonist Bosentan attenuates leukocyte-endothelial adhesion and inflammation in a rat model of IBD



Gastroenterology 118(4 Suppl 2 Part 1): AGA A570




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 034852395

Download citation: RISBibTeXText

DOI: 10.1016/s0016-5085(00)84416-9


Related references

Bosentan, an endothelin receptor antagonist, reduces leucocyte adhesion and inflammation in a murine model of inflammatory bowel disease. International Journal of Colorectal Disease 21(5): 409-418, 2005

Bosentan, a novel synthetic mixed-type endothelin receptor antagonist, attenuates acute gastric mucosal lesions induced by indomethacin and HCl in the rat: Role of endogenous endothelin-1. Journal of Gastroenterology 32(2): 164-170, 1997

Contribution of endothelin-1 to myocardial injury in a murine model of myocarditis: acute effects of bosentan, an endothelin receptor antagonist. Circulation 100(17): 1823-1829, 1999

Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice. Naunyn-Schmiedeberg's Archives of Pharmacology 388(11): 1211-1221, 2016

Beneficial effects of the endothelin receptor antagonist bosentan on myocardial and endothelial injury following ischaemia/reperfusion in the rat. European Journal Of Pharmacology. 283(1-3): 161-168, 1995

The endothelin-I receptor antagonist bosentan protects against ischaemia/reperfusion-induced endothelial dysfunction in humans. Clinical Science (London) 108(4): 357-363, 2005

The endothelin-1 receptor antagonist bosentan protects against ischaemia/reperfusion-induced endothelial dysfunction in humans. Clinical Science 108(4): 357-363, 2004

Thimerosal attenuates ischaemia-reperfusion arrhythmias in rats: No modification by anti-ischaemic agent trimetazidine or endothelin receptor antagonist bosentan. Pharmacological Research 34(1-2): 17-23, 1996

Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis. Arthritis and Rheumatism 56(6): 1985-1993, 2007

Effect of endothelin receptor antagonist bosentan on chronic hypoxia-induced inflammation and chemoafferent neuron adaptation in rat carotid body. High Altitude Medicine and Biology 13(3): 209-216, 2013

The nonpeptide endothelin receptor antagonist bosentan enhances myocardial recovery and endothelial function during reperfusion of the ischemic rat heart. Journal of Cardiovascular Pharmacology 26 Suppl 3: S445-S447, 1995

Efficacy of bosentan, a dual ETA and ETB endothelin receptor antagonist, in experimental diabetes induced vascular endothelial dysfunction and associated dementia in rats. Pharmacology, Biochemistry, and Behavior 124: 27-35, 2015

Combined use of ursodeoxycholic acid and bosentan prevents liver toxicity caused by endothelin receptor antagonist bosentan monotherapy: two case reports. Journal of Medical Case Reports 8: 250, 2015

Non-peptide endothelin receptor antagonist Bosentan attenuates gastric mucosal damage induced by local gastric ischemia reperfusion in rats. Gastroenterology 110(4 SUPPL ): A130, 1996

The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial. Diabetologia 55(3): 600-607, 2012